13. Coryell W, Zimmeman M: “Demographic, historical and symptomatic features of the nonmanic psychoses”. J Nerv Ment Dis 1986. 174:585-592.
14. Lykouras E, Christodoulou GN, Malliaras D: Type and content of delusions in unipolar psychotic depression. J Affect Disord 1985. 9:249-252
15. Nelson WH, Khan A, Orr WW: “Delusional depression: Phenomenology, neuroendocrine function, and tricyclic antidepressant response”. J Affect...
16. Carroll BJ, Fielding JM, Blashki TG. “Depression rating scales: a critical view”. Arch Gen Psychiatry 1973,28:361-366.
17. Nieremberg AA, Keefe BR, Leslie VC, et al. “Residual symptoms in depressed patients who respond acutely to fluoxetine”. J Clin Psychiatry...
18. Frank E, Prien RF,Jarret RB,et al. “Conceptualization and rationale for consensus definitions of terms in major depressive disorder”....
19. Riso Lp, Thase ME, Howland RH, et al. “A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed...
20. Guy W: ECDEU Assesment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76-33, Rockville, Md: National...
21. Andrew A. Nieremberg, M.D., and Lindsay M. DeCecco, B.A. “Definitions of antidepressant treatment response, remission, nonresponse, partial...
22. Black DW, Bell S, Hulbert J, et al: “The importance of axis II in patients with major depression: A controlled study”. J Affect Disord...
23. Hall RC, Gardner ER, Popkin ER, et al: “Unrecognized physical illness prompting psychiatric admission: A prospective study”. Am J Psychiatry...
24. Victor I, Reus MD: “Managemente of treatment-resistant unipolar and chronically depressed patients”. Psychiatric Clin of North Am. 1996....
25. Hansen CR, Malecha M, Mackenzie TB, et al: “Copper and zinc deficiencies in association with depression and neurological findings”. Biol...
26. Levitt AJ, Joffe RT: “Folate, B12, and life course of depressive illness. Biol Psychiatry” 1989 25:867-872.
27. Lidembaum J, Healton EB, Savage, DG,et al: “Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis”....
28. Stewart JW, Harrison W, Quitkin F, et al: “Low B6 levels in depressed outpatients”. Biol Psychiatry 1994;19:613-616
29. Danish University Antidepressant Group. “Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter...
30. Danish University Antidepressant Group. “Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance but weaker antidepressant...
31. Perry PJ. “Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake...
32. Thase ME, Frank E, Mallinger Ag, et al. “Treatment of imipramine-resistant recurrent depression, 3: efficacy of monoamine oxidase inhibitors”....
33. Liebowitz MR, Quitkin FM, Stewart JW,et al. “Antidepressant specificity in atypical depression. Arch Gen psychiatry” 1988;45:129-137
34. Quitkin FM, Rifkin A, Klein DF. “Monoamine oxidase inhibitors: a review of antidepressant effectiveness”. Arh Gen psychiatry 1979;36:749-760
35. Thase Me, Trivedi MH, Rush AJ. “MAOIs in the contemporary treatment of depression”. Neurophychopharmacology 1995; 12: 185-219
36. Pande AC, Birkett M, Fechner-Bates S et al. “Fluoxetine versus phenelzine in atypical depression”. Biol Psychiatry 1996;40:1017-1020
37. Keller MB, McCullogh JP, Klein DN, et al. “A comparation of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and...
38. Amsterdam J, Maislim G, Potter L: “Fluoxetine efficacy in treatment resistant depression”. Prog Neurophychopharm Biol Psychiatry 1994;18:143-261
39. Fawcet J, Kravitz HM, Zajacka JM, et al: “CNS stimulant potentiation of monoamine oxidase inhibitors in treatment refractory depression...
40. American Psychiatry Association. “Practice Guiedeline for the Treatment of Patients With Major Depressive Disorder (Revision)”. Am J Psychiatry...
41. Crismon ML, Trivedi M, Pigott TA, et al. “The Texas Medical Algorithm Projet: report of the Texas Consensus Conference Panel on Medication...
42. Amsterdam J, Maislim G, Potter L: “Fluoxetine efficacy in treatment ressistant depression”. Prog Neuropsychopharm Biol Psychiatry 1994,18:143-161
43. Lauren B, Marangell MD: “Switching Antidepressants for Treatment-Resistant Major Depression”. J Clin Psychiatry 2001;62 (suppl 18)12-17
44. Lessard E, Yessine MA, Hamelin BA, et al. “Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant...
45. Bhatara VS, Magnus RD, Paul KL, et al. “Serotonin syndrome induced by venlafaxine and fluoxetine: a case study in polypharmacy and potential...
46. John L, Perreault MM, Tao T, et al. “Serotonin syndrome associated with nefazodone and paroxetine”. Ann Emerg Med, 1997;29:287-289
47. Smith Dl, Wenegrat BG. “A case report of serotonin syndrome associated with combined nefazodone and fluoxetine (letter)”. J Clin Psychiatry...
48. Nolen WA, van de Putten JJ, Dijken WA, et al: “Treatment strategy in depression I. Non tricyclic and selective reuptake inhibitors in...
50. Beasley CM Jr, Sayler ME, Cunningham GE, et al: “Fluoxetine in tricyclic refractory major depressive disorder”. J Affect Disord 1990,...
51. Pande Ac, Calarco mm, Grunhaus LJ: “Combined MAOI-TCA treatment in refractory depression”. IN Amsterdam J (ed): Refractory Depression...
52. Sethna ER: “A study of refractory cases of depressive illnes and their response to combined antidepressant treatment”. Br J Psychiatry...
53. Fredman SJ, Fava M, Kienke AS, et al. “Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major...
54. Muricio Fava MD: “Augmentation and Combination Strategies in Treatment-Resistant Depression”. J Clin Psychiatry 2001;62(SUPPL 18) 4-11
55. Thase Me, Kupfer DJ, Frank E, et al: “Treatment of imipramine resistant recurrent depression: II _An open trial of lithium augmentation”....
56. Fink M: “A trial of ECT is essential before a diagnosis of refractory depression is made”. In: Refractory depression. Amsterdam JD, ed,...
57. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press,1990.
58. Price LH, Delgado PL, Charney DS, et al: “Sequence of drug administration in lithium augmentation: a case study”. J Clin Psychiatry 1988;49:161-162
59. Lôo H, Venisse JL. “Le Lithium est-il un antidepresseur?” Rev Med 1978,19:433-436
60. Price LH, Charney DS, Geninher DR: “Efficacy of lithium-tranylcipromine treatment in refractory depression”. Am J Psychiatry 1985;142:619-623
61. Ontiveros A, Fontaine R, Elie; R: “Refractory depression: the addition of lithium to fluoxetine or desipramine”. Acta Psychiatr Scand...
63. Hoencamp E, Haffmans j, Dijken WA, Huijbrechts IP. “Lithium augmentation of venlafaxine: an open-label trial”. J Clin Psychopharmacol...
64. Salama AA, Shafey M. “A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate” (letter) Am J Psychiatry...
65. Rybakowski JK, Suwalska A, Chlopocka M. “Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression”....
66. Malt UF, Fladvad T. “Lamotrigine in the tratment of mental disorders”. Tidsskr Nor Laegeforen 2001;121 (12):1473-7
67. Yasmin S, Carpenter LL, Leon Z, Siniscalchi JM, Price LH. “Adjunctive gabapentin in treatment-resistant depression: a retrospective chart...
68. Prange AJ Jr. “Novel uses of thyroid hormones in patients with affective disorders”. Thyroid 1996;6:537-543
69. Aronson R, Offman HJ, Joffe T, et al: “Triodothyronine augmentation in the treatment of the refractory depression: a meta-analysis”. Arch...
70. Targum SD, Greemberg RD, Harmon RL, et al: “The TRH test and thyroid hormone in refractory depression” (letter). Am J Psychiatry 1984;...
71. Earle BV: “Thyroid hormone and trycyclic antidepressant in resistant depression”. Am J Psychiatry 1970;126:143-145
72. Ostroff RB, Nelson JC. “Risperidone augmentation of selective serotonin reuptake inhibitors in major depression”. J Clin Psychiatry 1999;60:256-259
73. Weizman R, Weizman A. “Use of atypical antipsychotics in mood disorders”. Curr Opin Investig Drugs 2001 Jul;2(7):940-5
74. Shelton RC, Tollefson GD, Tohen M, et al. “A novel augmentation strategy for treating resistant major depression”. Am J Psychiatry 2001;158:131-134
75. Glassman AH, Platman SR: “Potentiation of monoamine oxidase inhibitor by tryptophan”. J Psychiatry Res 1969;7:83-88
76. Pare CMB: “Potentiation of monoamine oxidase inhibitors by tryptophan”. Lancret 1963 II;527-528
77. Berlanga C, Ortega-Soto HA, Ontiveros M, et al: “Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine”. Psychiatry...
78. Rudorfer MV, Potter WZ: “Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the never versos the...
79. Artigas F, Perez V, Alvarez E: “Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors”....
80. Blier P, Bergeron R: “Effectiveness of pindolol with selected antidepressants drugs in the treatment of major depression”. J Clin Pharmacol...
81. Olver JS, Cryan JF, Burrows GD, Norman Tr. “Pindolol augmentation of antidepressants: a review and rationale”. Aust NZJ Psychiatry 2000;34(1):71-9
82. Joffe RT Schuller DR: “An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression”. J Clin Psychiatry...
83. Bakish D: “Fluoxetine potentiation by buspirone: three case histories”. Can J Psychiatry 1991;36:749-750
84. Bakish D: “Fluoxetine potentiation by buspirone and trazodone in refractory depression”. In Novel WA, Zohar J, Roose SP, Amsterdam JD...
85. Jacobsen FM: “Possible augmentation of antidepressant response by buspirone”. J Clin Psychiatry 1991;52:217-220
86. Izumi T, Inoue T, Kitagawa N. “Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression”. J Affect Disord...
87. Wharton R, Perel J, dayton P, etal. “A potential clinical use for methylphenidate with tricyclic antidepressants”. Am J Psychiatry 1971;127:1619-1625
88. Nemets B, Mishory A, Levine J,et al. “Inositol addition does not improve depression in SSRI treatment failures”. J Neural Transm. 1999;106:795-798
89. Levine J, Mishory A, Sunosky M, et al. “Combination of inositol and serotonin reuptake inhibitors in the treatment of depression”. Biol...
90. Wolkowitz OM, Reus VI, Keebler A,etal.”Double blind treatment of major depression with dehydroepiandrosterone”. Am J psychiatry 1999;156:646-649
91. Coppen A, Bailey J. “Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised , placebo controlled trial”. J...
92. Bouwer C, Claassen J, Dinan TG, Nemeroff CB. “Prednisone augmentation in treatmentresistant depression with fatigue and hypocortisolaemia:a...
93. Bodani M, Sheehan B, Philpot M. “The use of dexamethasone in elderly patients with antidepressant-resistant depressive illness”. J Psychopharmacol...
94. Arana GW, Santos AB, Laraia MT, et al. “Dexamethasone for the treatment of depression: A randomized, placebo-controlled, double-bind trial”....
95. Beale MD, Arana GW. “Dexamethasone for treatment of major depression in patients with bipolar disorder” (letter). Am J Psychiatry 1995;152:959-960
96. Amsterdam JD, Rosenzweig M, Mozley PD. “Assessment of adrenocortical activity in refractory depression: Steroid supression with Ketoconazole”....
97. Ravaris CL, Brinck-Johnsen C, Elliott B. “Clinical use of ketoconazole in hypocortisoluric depressives”. Biol Psychiatry 1994;35:679.
98. Thakore JH, Dina TG. “Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression”....
99. Wolkowitz OM, Reus VI. “Treatment of depression with antiglucocorticoid drugs”. Psychosom Med 1999 Sep-Oct;61(5):698-711
100. Bodkin JA, Lasser Ra, Wines JD Jr, et al. “Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant...
101. Young SJ. “Panic associated with combining fluoxetine and bupropion” (letter). J Clin Psychiatry 1996;57:177-178
102. Labbate LA, Grimes JB, Hines A, et al. “Bupropion treatment of serotonin reuptake antidepressat-associated sexual dysfunction”. Ann Clin...
103. Ashton AK, Rosen RC. “Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction”. J Clin Psychiatry 1998;59:112-115
104. Farah A. “Relief of SSRI-induced sexual dysfunction with mirtazapine treatment” (letter). J Clin Psychiatry 1999;60:260-261
105. Carpenter LL, Yasmin S, Hall JM, et al. “Mirtazapine augmentation in the treatment of refractory depression”. J Clin Psychiatry 1999;60:45-49
107. Smith DL, Wenegrat BG. “A case report of serotonin syndrome associated with combined nefazodone and fluoxetine” (letter). J Clin Psychiatry...
108. John L, Perreault MM, Tao T, et al: “Serotonin syndrome associated with nefazodone and paroxetine”. Ann Emerg Med 1997;29:287-289
109. Seth R, Jennings AL, Brindman J, et al. “Combined treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression”....
110. Zajecka JM, Jeffries H, Fawcett J. “The efficacy of fluoxetine combined with heterocyclic antidepressant in treatment-resistant depression:...
111. Nelson JC, Mazure CM, Bowers MB, et al. “A preliminary open study of the combination of fluoxetine and desipramine for rapid treatment...
112. Bondolfi G, Chautems C, Rochat B, et al. “Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences...
113. Gillman PK. “Serotonin syndrome. History and risk”. Fun Clin Pharmacol 1998;12:482-491
114. Bhatara VS, Magnus RD, Paul KL, et al. “Serotonin syndrome induced by venlafaxine and fluoxetine: a case study in polypharmacy and potential...
115. Benazzi F. “Venlafaxine-fluoxetine interaction”. J Clin Psychopharmacol 1999;19:96-98
116. Hawley CJ, Sivakumaran T, Ochocki M, et al. “Co-administration of reboxetine and serotonin selective reuptake inhibitors in treatment-resistant...
117. Dursun Sm, Devarajan S. “The efficacy and safety of reboxetin plus citalopram in treatmentresistant depression: an open, naturalistic...
118. Fleishaker JC. “Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients...
119. Madhukar H, Trivedi MD, Beverly PhD. “Using treatment algorithms for the effective management of treatment-resistant depression”. J Clin...
120. Crismon ML, Trivedi MH, Pigott TA, et al. “The Texas Medication Algorithm Project: report of the Texas consensus conference panel on...
121. Star D: “Sequenced Treatment Alternatives to relieve Depression”. Available at: www.edc.gsph.pitt.edu/stard. Accessed March 8, 2001
122. Trivedi MH, Kleiber BA. “Algorithm for the treatment of chronic depression”. J Clin Psychiatry 2001;157:1501-1504
123. Trivedi MH,Kern JK, Baker SM,et al. “Computerized medical algorithms and decision support systems for major psychiatric disorders”. J...
